Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
Cre-dependent gene expression enables thymic development of autoreactive tumor-associated antigen targeting CAR-T cellsManpreet Bariana, Michael McGuire, Andrea Tuckett, et al.
Molecular Cancer Therapeutics|March 25, 2016
Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor GrowthJie Huang, Wei Hu, Limin Hu, et al.
The Prostate|March 10, 2018
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancerYishuo Wu, Hongjie Yu, S Lilly Zheng, et al.
Urologic Oncology|March 26, 2013
Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordanceDavid E Victorson, Penny S Brucker, Rita K Bode, et al.
Molecular Cancer Therapeutics|December 15, 2017
Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine CancerYan Huang, Wei Hu, Jie Huang, et al.
Genes & Development|July 13, 2017
PRKCI promotes immune suppression in ovarian cancerSharmistha Sarkar, Christopher A Bristow, Prasenjit Dey, et al.
Molecular Cancer Therapeutics|October 12, 2018
PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian CancerTakeshi Hisamatsu, Michael McGuire, Sherry Y Wu, et al.
Cancer Research|October 15, 2024
The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient TumorsLouise Cadzow, Jehrod Brenneman, Erica Tobin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2017
Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR ExpressionHeather J Dalton, Sunila Pradeep, Michael McGuire, et al.
Nature Communications|July 28, 2018
FABP4 as a key determinant of metastatic potential of ovarian cancerKshipra M Gharpure, Sunila Pradeep, Marta Sans, et al.
Pageof 6